Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov 16;6(1):21.
doi: 10.1186/1750-9378-6-21.

High-risk HPV infection after five years in a population-based cohort of Chilean women

Catterina Ferreccio  1 , Vanessa Van De Wyngard, Fabiola Olcay, M Angélica Domínguez, Klaus Puschel, Alejandro H Corvalán, Silvia Franceschi, Peter Jf Snijders
Affiliations

High-risk HPV infection after five years in a population-based cohort of Chilean women

Catterina Ferreccio et al. Infect Agent Cancer. .

Abstract

Background: The need to review cervical cancer prevention strategies has been triggered by the availability of new prevention tools linked to human papillomavirus (HPV): vaccines and screening tests. To consider these innovations, information on HPV type distribution and natural history is necessary. This is a five-year follow-up study of gynecological high-risk (HR) HPV infection among a Chilean population-based cohort of women.

Findings: A population-based random sample of 969 women from Santiago, Chile aged 17 years or older was enrolled in 2001 and revisited in 2006. At both visits they answered a survey on demographics and sexual history and provided a cervical sample for HPV DNA detection (GP5+/6+ primer-mediated PCR and Reverse line blot genotyping). Follow-up was completed by 576 (59.4%) women; 45 (4.6%) refused participation; most losses to follow-up were women who were unreachable, no longer eligible or had missing samples. HR-HPV prevalence increased by 43%. Incidence was highest in women < 20 years of age (19.4%) and lowest in women > 70 (0%); it was three times higher among women HR-HPV positive versus HPV negative at baseline (25.5% and 8.3%; OR 3.8, 95% CI 1.8-8.0). Type-specific persistence was 35.3%; it increased with age, from 0% in women < 30 years of age to 100% in women > 70. An enrollment Pap result ASCUS or worse was the only risk factor for being HR-HPV positive at both visits.

Conclusions: HR-HPV prevalence increased in the study population. All HR-HPV infections in women < 30 years old cleared, supporting the current recommendation of HR-HPV screening for women > 30 years.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ferreccio C, Prado R, Luzoro A, Ampuero SL, Snijders PJF, Meijer CJLM, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2271–6. - PubMed
    1. Ferreccio C, Corvalán A, Margozzini P, Viviani P, González C, Aguilera X, Gravitt PE. Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health. 2008;8:78. doi: 10.1186/1471-2458-8-78. - DOI - PMC - PubMed
    1. Departmento de Estadísticas e Información de Salud, Ministerio de Salud, Chile. http://deis.minsal.cl/vitales/Mortalidad_causa/Chile.htm last accessed August 24 2011.
    1. Jacobs MV, Walboomers JMM, Snijders PJF, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer. 2000;87:221–7. doi: 10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2. - DOI - PubMed
    1. González E, Molina T, Montero A, Martínez V, Leyton C. Comportamientos sexuales y diferencias de género en adolescentes usuarios de un sistema público de salud universitario. Rev Méd Chile. 2007;135(10):1261–1269. - PubMed